reports
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarte...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tuesday, May 14, 2024 after the market close. The Company will host a conference call to discuss the results the following morning, May 15th, at 8:30 a.m. ET. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of...
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected P...
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and . Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief, but as Dr...
Prestige Consumer Healthcare Inc: 2 directors
Two Directors at Prestige Consumer Healthcare Inc sold after exercising options/sold 56,038 shares at between 67.899USD and 68.353USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary ...
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Re...
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings Outlook to Approximately $4.33 TARRYTOWN, N.Y., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2023. “We are pleased with our continued strong results that exceeded our revenue and earnings expe...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1%...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredi...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday, February 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call v...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americai...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray to the consumer level. While benzene is not an ingredient in any Americaine® 20% Benzocaine Topical Anesthetic Spray products, a recent review by our manufacturer and their third-party lab found that a sample from one lot of the ...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2%...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene i...
Yelp Inc: 1 director
A director at Yelp Inc sold 57,071 shares at 45.718USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 R...
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results Revenue of $286.3 Million in Q2, Ahead of OutlookDiluted EPS of $1.07 in Q2, Up Over 5% Versus Prior YearReduced Leverage Ratio to 3.0x at Quarter EndReaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2023. “Our second quarter results build on a strong first quarter performance thanks to our di...
- Dan Salmon
- Emily Stykes
The Weekend Wrap: Chrome tests new IP address protections, META’s Inst...
What’s New: In our latest edition, we share our views on : 1. GOOGL’s Chrome begins testing new IP address protections 2. META expands Instagram’s Reminder Ads 3. MTCH’s Tinder adds match-making feature 4. YELP makes several AI upgrades 5. TikTok Testing 15 Minute Videos
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarte...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call v...
Prestige Consumer Healthcare to Present at the Barclays Global Consume...
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET. All interested parties may access a live webcast of this event at under the "Investors” section and the "Events and Presentations" tab, or by using the following link: For those unable to participate during the live webcast, a replay option will be available on t...
- Dan Salmon
- Emily Stykes
2Q23 Digital Ads Recap: Returns to Scale
In our expanded 2Q23 Digital Ad Recap, we review performance across six sub-sectors and 41 companies (see below) and also make slight adjustments to our industry model. 1. Search: GOOGL, MSFT, IAC, YELP, ANGI, PERI 2. Social Media: META, SNAP, PINS, YouTube 3. Retail Media: AMZN, EBAY, CRTO 4. Streaming: NFLX, DIS, ROKU, WBD, NBCU, PARA 5. Agencies: OMC, IPG, WPP-LN, PUB-FR, STGW, Dentsu 6. Ad Tech, including: 1. Demand-side platforms (DSPs): TTD, CRTO, PERI, DSP, ADTH, CDLX 2. Sell-side platf...
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Re...
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results Revenue of $279.3 Million in Q1, up 0.8% versus Prior Year and up 1.8% excluding Foreign CurrencyReduced Leverage Ratio to 3.2x at Quarter End and Completed $25 Million Share Repurchase ProgramReaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2023. “We are pleased with our first quarter results that delivered a stron...
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earn...
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first quarter earnings release on Thursday, August 3, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call via phone,...
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report TARRYTOWN, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced the release of its inaugural Environmental, Social, and Corporate Governance (ESG) Sustainability Report. The report highlights the Company’s ESG attributes and the steps it has taken to establish baselines to measure the Company’s sustainability strategy. The Company’s ESG framework is centered on three pillars – supporting an inclusive workforce, responsible corporate citizens...
Prestige Consumer Healthcare to Present at Upcoming Investor Conferenc...
Prestige Consumer Healthcare to Present at Upcoming Investor Conferences TARRYTOWN, N.Y., June 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 6, 2023 at 1:00 p.m. ET. The following week, the Company will participate in a fireside chat at the Oppenheimer Consumer Growth & E-Commerce Conference virtually on Monday, June 12, 2023 at 9:45 a.m. ET. All interested parties may access a live webcast of these events at under the "Investors” section and the "Events a...
Goody’s® Introduces New “GET TO GOOD™” Marketing Campaign
Goody’s® Introduces New “GET TO GOOD™” Marketing Campaign The Powdered Pain Relief Brand Highlights Typical Consumers Who Cannot Let Discomfort Slow Them Down TARRYTOWN, N.Y., May 31, 2023 (GLOBE NEWSWIRE) -- Goody’s®, the fast acting, over-the-counter pain reliever in single dose powder form, announces the launch of its new national marketing campaign. The trusted brand in the south for over 90 years, Goody’s®, a Prestige Consumer Healthcare brand, will now be showcased countrywide with “GET TO GOOD™” featuring a diverse cast of characters including a makeup artist, weekend warrior, an...
Dramamine® Eases Americans’ Travel Woes with ‘Ditch the Drama’ Sweepst...
Dramamine® Eases Americans’ Travel Woes with ‘Ditch the Drama’ Sweepstakes Offering a Vacation to Anywhere in the World This comes as 72% of Americans say they prefer someone else handle the planning for them, and nearly a third of Americans saying their plans won’t be finalized until weeks before. TARRYTOWN, N.Y., May 23, 2023 (GLOBE NEWSWIRE) -- Memorial Day is quickly approaching, leaving millions of Americans scrambling to finalize their travel plans before the rush of summer travel season. According to a recent survey* from , a Prestige Consumer Healthcare brand and the #1 pharmaci...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.